Monopar stock rallies 60% on Phase 1 data for MNPR-101-Zr Source: (*1*)
Browsing: Phase
(*3*) Sanofi reports positive Phase 3 results for Dupixent for CSU Source: Seekingalpha
(*2*) BriaCell stock rockets 150% on positive Phase 2 data for Bria-IMT Source: Seekingalpha
(*3*) Sanofi reports positive Phase 3 results for Dupixent for CSU Source: Seekingalpha
(*2*) BriaCell stock rockets 150% on positive Phase 2 data for Bria-IMT Source: Seekingalpha
Panama7 Sanofi (NASDAQ:SNY) reported positive results for a Phase 3 research of its drug Dupixent within the therapy of continual spontaneous urticaria, or CSU, which it…
(*2*) Devonyu Shares of BriaCell Therapeutics (NASDAQ:BCTX) soared 150% in morning buying and selling Wednesday after the corporate reported positive total survival data from a Phase…
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750 Source: (*1*)
Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750 Source: (*1*)
AstraZeneca reports disappointing Phase 3 data for lung cancer ADC (*3*) Source: Seekingalpha